Gut check: new study targets stomach woes in female athletes
NCT ID NCT07366931
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a daily postbiotic supplement (humiome® post LB) can reduce gastrointestinal symptoms like bloating and discomfort in 100 female athletes. Participants will take the supplement or a placebo for several weeks, and researchers will track symptoms during exercise and across menstrual cycle phases. The goal is to find a simple, non-drug way to help female athletes manage gut issues that often disrupt training and performance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 1/2
Runs two stages together: safety and dose first, then whether the treatment works.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Female, cisgender, premenopausal. 2. Minimum age 18 years. 3. Regular, natural menstrual cycle (21-35 days in duration), with 9 or more consecutive periods per year, if possible documented with tracker apps, calendars, or other tools. 4. Willingness and ability to give informed consent and to understand, to participate, and to comply with the clinical study requirements. 5. Body mass index (BMI) ≥ 18.5 and \< 24.9 kg/m2 6. Agreeing to maintain lifestyle habits during the study (same dietary and physical activity habits) 7. Having a smartphone and a history of consistent tracking of training and health records via apps. 8. Having regular GI issues during exercise, preferably also during menstruation. During pre-screening, this will be assessed with a shortened GSRS questionnaire, where participants need to have had, in the month preceding pre-screening, the equivalent of at least a score of 2 in a GSRS focus area (diarrhoea, pain, indigestion). 9. No relevant self-reported abnormalities from medical history. 10. Trained athlete (trains at least 3 times per week for more than 1 hour per day and who has been involved in endurance training for at least 2 years in alignment with previous research (Pfeiffer et al., 2010). This will be evaluated by assessing training records (Strava or similar application, certificates of attendance to athletic events, club membership, etc.). 11. Access to a health-care provider, who can be contacted by the CRO, and who reside in areas with available health services. Exclusion Criteria: 1. Individuals who are pregnant, lactating, or plan to become pregnant before study end. 2. Individuals with secondary amenorrhea. 3. Individuals who use hormonal contraceptives during the last 6 months before (and during) the trial. 4. Individuals who are currently participating in another clinical trial or have participated in a trial within the last two months prior to enrolment. 5. Tobacco smokers and vapers. 6. Individuals with acute illness. 7. Individuals with a current musculoskeletal injury or one within the last month. 8. Individuals taking probiotic supplements or who have taken probiotics two weeks prior to enrolment. 9. Individuals controlling chronic diseases with treatments known to alter the intestinal microbiome or to alter GI symptoms, such as certain pain killers, antacids, proton-pump inhibitors, anti-diarrhoeal medication or supplements, and laxatives. 10. Individuals having received antibiotics treatments within three months of trial start. 11. Individuals having planned major changes in lifestyle (i.e. diet, weight loss program, exercise level, travelling) during the duration of the study. 12. Individuals who have any hypersensitivity/allergy to any of the components of the test product. 13. Individuals who have planned major elective surgery during the study period.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gastrointestinal symptoms are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Liverpool John Moores University
Liverpool, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Viruses that eat bacteria: can phages quiet a troubled gut?
- A daily capsule that could turn back the clock on facial aging?
- Can a wheatgrass bread boost your gut microbiome?
- Corn's hidden markers: a meal that could tell us who eats whole grains
- Fiber and probiotics: a new hope for bloating and irregularity?
- Can a daily drop of botanicals soothe your gut and lift your energy?